Pharma, PBMs spar over rising drug costs amid public scrutiny

Dollar bill and doctor prescription with pills lie on doctor table in clinic closeup

Nadzeya Haroshka

The top pharmaceutical lobby group, PhRMA, and drug middlemen known as pharmacy benefit managers (PBM) have resumed their long-running battle over who is to blame for rising drug costs in the U.S. amid growing public scrutiny.

The Biden Administration implementedthe first time in history.

Leave a Comment